Prevalence of Herbal Medicine use among Pregnant Women Attending Antenatal care at Jimma University Medical Center, Jimma, Southwest Ethiopia

Abstract

Background: The use of herbal medicine during pregnancy for different indications now a day becomes common across globally. Its use is increasing, especially in developing countries. It is estimated that 65%-80% of the population use herbal products Objectives: This study aimed to assess the prevalence of herbal medicine use among pregnant women attending Antenatal care at Jimma University medical center, Southwestern Ethiopia. Methods: A cross-sectional study design was employed to conduct the study. Data was collected by data collectors using data abstraction formats, then entered and analyzed using SPSS version 26.0. Frequency and percentage were computed as summary statistics. Results:  A total of 341 pregnant women attending antenatal care were enrolled in the study, of which 331 participated in the study. Out of 331 pregnant women who participated in the study, 3.93% of them practiced self-medication with herbal medicine during their current pregnancy. Conclusions: The most frequently practiced herbal medicine among pregnant women attending antenatal care at JUMC were Ginger and Damakese with the most common clinical indication of vomiting and headache respectively. The source of information for the participant's herbal medicine use were mostly family and friends.

Competing Interest Statement

The authors have no any competing interest

Funding Statement

Not applicable

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Jimma University Institute of health Institutional Review Board (IRB) (ref. no. JUIH 143422/22) in Ethiopia

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data sets are available

留言 (0)

沒有登入
gif